Learner Notification
2024 Cord Blood Connect | September 6–8, 2024 | Miami Beach, FL
How to Get Your Certificate
- Go to cba.cmecertificateonline.com
- Click on the 2024 Cord Blood Connect link.
- Evaluate the meeting.
- Print, download, or save your certificate for your records.
- If you lose your certificate, or need help, go to help.cmecertificateonline.com
The deadline to complete CME evaluations is December 31, 2024.
Acknowledgment of Financial Commercial Support No financial commercial support was received for this educational activity.
Acknowledgement of In-Kind Commercial Support No in-kind commercial support was received for this educational activity.
Satisfactory Completion Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Joint Accreditation Statement In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Cord Blood Association. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Professions in scope for this activity are listed below.
Amedco Joint Accreditation Provider Number: 4008163
Physicians ACCME Credit Designation Statement Amedco LLC designates this live activity for a maximum of 17.25 AMA PRA Category 1 Credits™ for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Professions Florida Board of Clinical Laboratory Personnel (FL CLS) Credit Designation Statement This course has been approved by the Florida Board of Clinical Laboratory Personnel for 17.25 hours of Clinical Laboratory Director, Clinical Laboratory Supervisor, Clinical Laboratory Technician, Clinical Laboratory Technologist. Program Provider: Amedco.
Course Approval Number: 20-1216388
American Society for Clinical Pathology (ASCP) Credit Designation Statement This continuing medical laboratory education activity is recognized by the American Society for Clinical Pathology for 17.25 CMLE credit. ASCP CMLE credits are acceptable for the ASCP Board of Registry Certification Maintenance.
Objectives - After Attending This Program You Should Be Able To:
- Report on the state-of-the-art in cord blood and perinatal tissue therapies.
- Analyze contemporary and new methods for collecting, processing, banking and releasing cord blood and perinatal tissue products.
- Discuss current procedures, methods and issues in cord blood and tissue processing, manufacturing, regulation, accreditation and public education.
Disclosure of Conflict of Interest The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5)
All individuals in a position to control the content of CE are listed below.
Name
|
Commercial Interest:Relationship
|
Joy Aho
|
NA
|
Tomasz Baran
|
PBKM/FamiCord Group, Vita 34 AG:Corporate Board Member Vita 34 AG:Public Stock Shareholder
|
Juliet Barker
|
NA
|
Peter Bawin
|
NA
|
Andrea Bradford
|
NA
|
Kate Brempelis
|
NA
|
John Centanni
|
NA
|
Amanda Conerty
|
NA
|
Colleen Delaney
|
Deverra Therapeutics:Private Stock Shareholder Deverra Therapeutics, Coeptis Therapeutics:Employee Deverra Therapeutics:Corporate Board Member BioLife Solutions, Celaid:Scientific/Medical Advisory Board Member Coeptics Therapeutics:Public Stock Shareholder
|
Ngaire Elwood
|
NA
|
Kate Falcon-Girard
|
ViaCord/Revvity:Employee
|
Ali Fatemi
|
Minoryx, Viking Therapeutics, Poxel Therapeutics:Research Grant Site Principal Investigator
|
Marcie Finney
|
NA
|
Karen Foster
|
NA
|
Mahasweta Gooptu
|
NA
|
Roger Horton
|
NA
|
Mitchell Horwitz
|
NA
|
Dunia Jawdat
|
NA
|
Antonio Jimenez
|
NA
|
Junya Kanda
|
NA
|
Joanne Kurtzberg
|
NA
|
Bernhard Lehnertz
|
NA
|
Abeer Madbouly
|
NA
|
Chris Mains
|
NA
|
Peter Marks
|
NA
|
Cary Martinez
|
NA
|
Aby J. Mathew
|
NA
|
Christina Melief
|
NA
|
Leland Metheny
|
Incyte:Speakers Bureau Pfizer:Scientific/Medical Advisory Board Member
|
Ericka Narr
|
NA
|
Hidekazu Nishikii
|
NA
|
Charis Ober
|
NA
|
Amanda Olson
|
NA
|
Loannis Politikos
|
Merck:Research Grant Site Principal Investigator ExcellThera, Precisionheor:Other
|
Suzanne Pontow
|
NA
|
Hemalatha Rangarajan
|
Medexus:Consultant
|
James Ropa
|
NA
|
Anne Rugari
|
NA
|
Guy Sauvageau
|
ExCellThera:Owner
|
Srividhya Senthil
|
NA
|
Shalini Shenoy
|
Bluebird Bio, Medexus, BioLine Rx:Consultant BEAM Therapeutics:Other
|
Elizabeth Shpall
|
Navan Technologies, Axio Research, Zelluna Immunotherapy, National Marrow Donor Program, FibroBiologics, Affimed, Syena, Takeda:Other Adaptimmune, Celaid Therapeutics Inc:Consultant
|
Felician Stancioiu
|
Biogenis SRL, Stem Cell Life:Consultant Janssen Research and Development:Scientific/Medical Advisory Board Member
|
Jeremy Sugarman
|
Merck KGaA, IQVIA, Aspen Neurosciences, Inc:Scientific/Medical Advisory Board Member Merck:Consultant
|
Jessica Sun
|
CryoCell International, LTD:Other
|
Asako Uchimaya
|
NA
|
Ana Valverde
|
NA
|
Wouter Van't Hof
|
NA
|
Fran Verter
|
NA
|
Roberto Waddington
|
CryoHoldco:Employee
|
Robert Wynn
|
NA
|
Ryan Smith
|
NA
|
Ryan Dixon
|
NA
|
|